{
    "rcn": "198798",
    "acronym": "EAVI2020",
    "topics": "PHC-09-2015",
    "title": "European AIDS Vaccine Initiative 2020",
    "startDate": "01/11/2015",
    "endDate": "31/10/2020",
    "objective": "HIV-1 is responsible for a global pandemic of 35 million people, and continues to spread at a rate of >2 million new infections/year. It is widely acknowledged that a protective vaccine would be the most effective means to reduce HIV-1 spread and ultimately eliminate the pandemic, while a therapeutic vaccine may help mitigate the clinical course of disease and lead to strategies of viral eradication. However despite 30 years of research, we do not have a vaccine capable of protecting from HIV-1 infection or impacting on disease progression. This in part represents the challenge of identifying immunogens and vaccine modalities with reduced risk of failure in late stage development. To overcome this bottleneck some of the most competitive research groups in vaccine discovery from European public institutions and biotechs from 9 EU countries together with top Australian and Canadian groups and US collaborators, have agreed to join forces in EAVI, providing a pool of international expertise at the highest level. EAVI2020 will provide a platform for the discovery and selection of several new, diverse and novel preventive and/or therapeutic vaccine candidates for HIV/AIDS. Emphasis will be placed on early rapid, iterative, small Experimental medicine (EM) human vaccine studies to select and refine the best immunogens, adjuvants, vectors, homologous and heterologous primeñboost schedules, and determine the impact of host factors such as gender and genetics. Animal models will be used to complement human studies, and to select novel immunization technologies to be advanced to the clinic. To shift the ìrisk curveî in product development we will develop innovative risk prediction methods, specifically designed to reduce the risk associated with late stage preventive or therapeutic vaccine failure, increasing the chance of discovery of an effective vaccine.",
    "totalCost": "24088765",
    "ecMaxContribution": "22948022,25",
    "coordinator": "IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE",
    "coordinatorCountry": "UK",
    "participants": "INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;BIONTECH RNA PHARMACEUTICALS GMBH;Genome Research Limited;INSTITUTO DE SALUD CARLOS III;COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES;FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA;STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE THE NETHERLANDS;ISTITUTO SUPERIORE DI SANITA;UNIVERSITY OF NEW SOUTH WALES;FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA;NEMZETI ELELMISZERLANC-BIZTONSAGI HIVATAL;INTERNATIONAL AIDS VACCINE INITIATIVE INC;THE UNIVERSITY OF WESTERN ONTARIO;UNIVERSITE JOSEPH FOURIER GRENOBLE 1;LUDWIG BOLTZMANN GESELLSCHAFT GMBH;OSPEDALE SAN RAFFAELE SRL;POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH;UNIVERSITE GRENOBLE ALPES;KAROLINSKA INSTITUTET;UNIVERSITY OF MELBOURNE;THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD;UNIVERSITATSKLINIKUM ERLANGEN;Academisch Medisch Centrum bij de Universiteit van Amsterdam;KING'S COLLEGE LONDON",
    "participantCountries": "FR;DE;UK;ES;NL;IT;AU;HU;US;CA;AT;SE",
    "projectParticipants": {
        "999907429": {
            "orgId": "999907429",
            "orgName": "UNIVERSITE JOSEPH FOURIER GRENOBLE 1",
            "ecContrib": 0
        },
        "999993468": {
            "orgId": "999993468",
            "orgName": "IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE",
            "ecContrib": 6122541
        },
        "999555319": {
            "orgId": "999555319",
            "orgName": "NEMZETI ELELMISZERLANC-BIZTONSAGI HIVATAL",
            "ecContrib": 211299
        },
        "999981343": {
            "orgId": "999981343",
            "orgName": "GENOME RESEARCH LIMITED",
            "ecContrib": 0
        },
        "998732274": {
            "orgId": "998732274",
            "orgName": "Academisch Medisch Centrum bij de Universiteit van Amsterdam",
            "ecContrib": 571500
        },
        "918157769": {
            "orgId": "918157769",
            "orgName": "INTERNATIONAL AIDS VACCINE INITIATIVE INC",
            "ecContrib": 626000
        },
        "999992401": {
            "orgId": "999992401",
            "orgName": "COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES",
            "ecContrib": 1390635
        },
        "988059752": {
            "orgId": "988059752",
            "orgName": "THE UNIVERSITY OF WESTERN ONTARIO",
            "ecContrib": 0
        },
        "998090910": {
            "orgId": "998090910",
            "orgName": "UNIVERSITY OF NEW SOUTH WALES",
            "ecContrib": 0
        },
        "999978530": {
            "orgId": "999978530",
            "orgName": "KAROLINSKA INSTITUTET",
            "ecContrib": 895561
        },
        "999694514": {
            "orgId": "999694514",
            "orgName": "POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH",
            "ecContrib": 3449000
        },
        "999507886": {
            "orgId": "999507886",
            "orgName": "INSTITUTO DE SALUD CARLOS III",
            "ecContrib": 403829
        },
        "998399079": {
            "orgId": "998399079",
            "orgName": "LUDWIG BOLTZMANN GESELLSCHAFT GMBH",
            "ecContrib": 201250
        },
        "997382131": {
            "orgId": "997382131",
            "orgName": "FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA",
            "ecContrib": 1998031
        },
        "999978821": {
            "orgId": "999978821",
            "orgName": "ISTITUTO SUPERIORE DI SANITA",
            "ecContrib": 389700
        },
        "959608488": {
            "orgId": "959608488",
            "orgName": "BIONTECH RNA PHARMACEUTICALS GMBH",
            "ecContrib": 371375
        },
        "999997833": {
            "orgId": "999997833",
            "orgName": "INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE",
            "ecContrib": 1140062
        },
        "999866495": {
            "orgId": "999866495",
            "orgName": "UNIVERSITATSKLINIKUM ERLANGEN",
            "ecContrib": 564021
        },
        "934841575": {
            "orgId": "934841575",
            "orgName": "STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE THE NETHERLANDS",
            "ecContrib": 0
        },
        "999658818": {
            "orgId": "999658818",
            "orgName": "UNIVERSITY OF MELBOURNE",
            "ecContrib": 0
        },
        "924833212": {
            "orgId": "924833212",
            "orgName": "UNIVERSITE GRENOBLE ALPES",
            "ecContrib": 612908
        },
        "953176030": {
            "orgId": "953176030",
            "orgName": "OSPEDALE SAN RAFFAELE SRL",
            "ecContrib": 669939
        },
        "999984350": {
            "orgId": "999984350",
            "orgName": "THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD",
            "ecContrib": 2510759
        },
        "999981052": {
            "orgId": "999981052",
            "orgName": "KING'S COLLEGE LONDON",
            "ecContrib": 190612
        }
    },
    "calculatedTotalContribution": 22319022
}